Please do not leave this page until complete. This can take a few moments.
People are used to hearing about research with the potential to cure or mitigate some of life’s many diseases.
Psychemedics Corp. of Acton said it ended the first quarter with a $39,000 profit on $4.1 million in revenue, both significant declines from a year ago.
Fitchburg-based Arrhythmia Research Technology Inc. and its wholly owned subsidiary Micron Products Inc. said "continuing price erosion" was in part responsible for its weak first quarter performance.
Framingham-based GTC Biotherapeutics Inc. said its anti-clotting drug ATryn is now commercially available in the United States.
A skin treatment laser made by Wayland-based Candela Corp. has been approved for use in Canada.The carbon dioxide laser is already in use in the United States, Europe and Australia.
RXi Pharmaceuticals Corp. of Worcester bas appointed Richard Chin, CEO of the nonprofit pharmaceutical company Institute for OneWorld Health, to its board of directors.
Oxford-based laser maker IPG Photonics Corp. reported a first quarter revenue decrease of 14 percent, as well as operating income and profit declines of 84 percent.
Exact Sciences Corp. said its new relationship with pharmaceutical and biotech giant Genzyme Corp. boosted the company's first quarter revenue, but deepened its quarterly loss.
Franklin-based medical device maker PLC Systems Inc. says it has inked a distribution deal to bring its key product to Spain.
A Burlington company has acquired Maynard telephone software provider Convergence Inc. for about $22.8 million.
Holliston life science tools company Harvard Bioscience Inc. saw its Q1 revenues drop 13.2 percent to
The Massachusetts Life Sciences Center awarded a total of $3.4 million in accelerator loans today for early stage biotechnology companies, including one in Marlborough and one in Westborough, accordin
Milford-based Waters Corp. has sold chromatography equipment to the U.S. Drug Enforcement Agency, which intends to use it to train forensic chemists.
Milford-based laboratory equipment maker Waters Corp. reported a first quarter profit of $73.3 million, up from $68.5 million a year ago despite a 10 percent decline in sales.
Marlborough pharmaceutical company Sepracor Inc. says a phase III study of its nasal aerosol hay fever treatment had positive results.
Thermo Fisher Scientific Inc. has entered into an agreement to buy Australian life science equipment company Biolab for about $120 million.